BiomX

About

Funding history · 19 rounds · $163.3M total

Acquisitions · 4

Headcount over time

Offices

Q&A

What was the most recent funding round for BiomX?

BiomX completed a PIPE funding round in February 2025, raising $12,000,000.

What was the most recent acquisition made by BiomX?

BiomX acquired Zorronet in April 2026.

Who is the current CEO of BiomX?

Michael Oster is the CEO of BiomX, appointed in March 2026.

What is the primary focus of BiomX?

BiomX is a clinical-stage biotechnology company developing natural and engineered phage therapies to target pathogenic bacteria underlying chronic and infectious diseases.

What was the outcome of the Phase 2b BX004 trial for Cystic Fibrosis?

In December 2025, BiomX announced the discontinuation of the Phase 2b BX004 trial following an internal review.

What is the status of BiomX's BX211 program for Diabetic Foot Osteomyelitis (DFO)?

In March 2025, BiomX announced positive topline results from the Phase 2 trial evaluating BX211 for the treatment of Diabetic Foot Osteomyelitis (DFO).

What is the status of BiomX's listing on the NYSE American?

In June 2026, BiomX announced NYSE American's acceptance of its plan to regain compliance with listing standards.

What is BiomX's involvement in the security and defense markets?

In March 2026, BiomX launched a security subsidiary in Israel, intending to invest over $3 million in its operations to expand its presence in security and defense markets.

Team · 19

Rotem Sorek

Founder · Founder

Eran Elinav

Founder · Founder

Timothy K. Lu

Founder · Founder

Naomi Zak

Founder · Co-Founder

Michael Oster

Chief Executive Officer

David Rokach

Chief Financial Officer

Yaron Breski

Board Member

Eric de la Fortelle

Board Member

Liat Bidas

Director, Audit Committee Chair

Guy Arieli

Director

Shaked Ran

Director

Amir Shalom

Director

Reuven Yeganeh

Class 1 Director

Dr. Ehud (Udi) Levi

Advisory Board Member

Urania Rappo

Senior Director, Clinical Development

Roy Opperman

Director Of Intellectual Property

Neta Tobis

Director Of Clinical Operations

Yaron Tzur

Director Of Process Development And Manufacturing

Alan Moses

Director Board Of Directors

Sectors & technology

Highlights

Tags